The Most Powerful Healthcare Advertising Platform

A healthcare advertising platform that empowers marketers to plan, activate, measure and optimize HCP and patient programmatic campaigns, all within a single platform.

DeepIntent Healthcare Platform

Proven to drive higher audience quality and script lift


Create highly-qualified patient and HCP audience segments and forecast real-time performance potential to reach your most clinically-relevant audiences.

Build custom HCP and patient audiences based on the the industry’s most comprehensive healthcare dataset

Access clinically-precise audiences from the first and only healthcare data marketplace

Onboard existing segments to our data-agnostic platform

Reach HCPs who are actively treating, or about to treat, relevant patients, using eligibility and labs data


Address your audiences immediately using our homegrown, award-winning DSP. Trade directly with publishers, buy across the open exchange, and access the first Connected TV Marketplace built for healthcare advertisers.

Reach more than 75%+ of addressable CTV households with curated inventory from programmers like Hulu, NBCUniversal, and Discovery+

Tap into the only healthcare DSP integrated with LG TV viewership data

Enjoy zero-fee trading on direct deals with leading publishers, like Haymarket, Bulletin Healthcare, and Everyday Health

Seamlessly activate custom or ready-to-use patient and HCP audience segments via Audience Marketplace

Dynamically update HCP target lists with seamless platform integrations


Drive higher audience quality and script lift with DeepIntent Outcomes™, our patented, award-winning solution that automatically optimizes live campaigns based on real-world clinical data and machine learning.

Proven to improve performance for patient, HCP, and integrated campaigns

Insightful analysis to understand and improve performance drivers within and across campaigns

Daily provider-level data (PLD) reporting for all HCP audiences

DeepIntent Healthcare Advertising Platform

Are you ready to see the platform in action?

CTV Family

Data and Identity Foundation Built for a Cookieless Future Since 2019​


Maximize cookieless reach with our proprietary identity solution that directly connects healthcare datasets to anonymized clinical, behavioral, CRM, and first-party publisher data in real time

Identity Data Partners
Discover the first and only cookieless by design HCP and patient data marketplace, powered by the industry’s leading identity graph

Access one of the first demand side platforms integrated with LiveRamp RampID for cookieless bidding and biddable IDs


Leverage direct integrations with publisher first-party data, such as NPIs and hashed emails, via DeepIntent’s Healthcare Marketplace

couple together ipad

Our Commitment to a Privacy-First and Brand-Safe Advertising Environment​


Create unique, personalized, and relevant messaging in a privacy-compliant way


Protect patient identity with a patented modeling process that combines artificial intelligence and emerging privacy technologies, like differential privacy


Achieve a high viewability, brand-safe environment with industry-leading verification partners such as DoubleVerify and Integral Ad Sciences (IAS)

How Sun Pharma and Fingerpaint Grew Verified Patient Reach 5.7X

DeepIntent Outcomes™ machine learning algorithms auto-optimized all campaign parameters in-flight, helping Sun Pharma and its consumer agency of record, Fingerpaint, raise awareness for ILUMYA® while decreasing cost-per-verified patient by 83%.

More Insights

Case Studies
Revolutionizing Healthcare Advertising: How DeepIntent Outcomes™ Delivers Exceptional Performance for Leading Pharma Brands
Proven to drive audience quality (AQ) and script lift, DeepIntent Outcomes™ is the industry's fastest cross-platform measurement solution based on clinical data. Download our eBooklet...
Read More
Driving NBRx and Improving AQ with Outcomes
Blog Post
Driving NBRx and Improving AQ: How DeepIntent Outcomes Delivers for Pharma Advertisers
There are more than 20,000 prescription drugs approved for marketing by the Food and Drug Administration (FDA). And yet, they all have one big thing...
Read More
senior couple watching TV
Press Release
DeepIntent and Roku Research Reveals 79% of Adults 50+ Stream, Are More Amenable to Advertising Than the General Population
Unveiled at DeepIntent’s second annual Innovating with Intent event, research highlights the opportunities pharma brands have to reach adults 50 and over with relevant CTV...
Read More

Schedule a Live Demo

Back to Top